Showing 821 - 840 results of 15,663 for search '(( six ((nn decrease) OR (a decrease)) ) OR ( i ((largest decrease) OR (larger decrease)) ))', query time: 0.66s Refine Results
  1. 821

    NIH score. by Zahra Tajik (20752452)

    Published 2025
    “…The results show that one month after the NSPT, there was no significant difference in the mean visfatin level of GCF (SMD: -3.91, 95%CI: -9.83, 2.01, p = 0.195, I-square, 96.6%, random effect model, n = 2) and serum (SMD: -0.33, 95%CI: -0.98, 0.33, p = 0.332, fixed effect model, n = 1), but 2, 3 and 6 months after NSPT, the mean visfatin level of GCF and serum decreased significantly. There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
  2. 822

    List of excluded studies. by Zahra Tajik (20752452)

    Published 2025
    “…The results show that one month after the NSPT, there was no significant difference in the mean visfatin level of GCF (SMD: -3.91, 95%CI: -9.83, 2.01, p = 0.195, I-square, 96.6%, random effect model, n = 2) and serum (SMD: -0.33, 95%CI: -0.98, 0.33, p = 0.332, fixed effect model, n = 1), but 2, 3 and 6 months after NSPT, the mean visfatin level of GCF and serum decreased significantly. There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
  3. 823
  4. 824
  5. 825
  6. 826
  7. 827
  8. 828
  9. 829

    Fig 3 - by Xiaohua Zhuang (11890694)

    Published 2021
    Subjects:
  10. 830
  11. 831
  12. 832

    Data set. by Yukiko Namba (6829589)

    Published 2023
    Subjects:
  13. 833
  14. 834
  15. 835

    A Yoga Strengthening Program Designed to Minimize the Knee Adduction Moment for Women with Knee Osteoarthritis: A Proof-Of-Principle Cohort Study by Elora C. Brenneman (795723)

    Published 2015
    “…A secondary objective was to determine whether the program could improve mobility and fitness, and decrease peak KAM during gait. …”
  16. 836

    The effect of the use of a decision aid with individual risk estimation on the mode of delivery after a caesarean section: A prospective cohort study by Emy Vankan (7435055)

    Published 2019
    “…</p><p>Methods</p><p>We performed a prospective cohort study. From 2012 to 2014, 483 women in six hospitals, where the DA was used (intervention group), were compared with 441 women in six matched hospitals (control group). …”
  17. 837

    Improved high sensitivity screen for Huntington disease using a one-step triplet-primed PCR and melting curve assay by Mingjue Zhao (654744)

    Published 2017
    “…The assay was optimized on 30 genotype-known DNAs, and two plasmids p<i>HTT</i>(CAG)<sub>26</sub> and p<i>HTT</i>(CAG)<sub>33</sub> were used to establish the threshold temperatures (TTs) distinguishing normal from expansion-positive samples. …”
  18. 838
  19. 839
  20. 840